Cargando…

CSF placental growth factor – a novel candidate biomarker of frontotemporal dementia

OBJECTIVE: Diagnosis of frontotemporal dementia (FTD) is complicated by the overlap of clinical symptoms with other dementia disorders. Development of robust fluid biomarkers is critical to improve the diagnostic work‐up of FTD. METHODS: CSF concentrations of placental growth factor (PlGF) were meas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hansson, Oskar, Santillo, Alexander F., Meeter, Lieke H., Nilsson, Karin, Landqvist Waldö, Maria, Nilsson, Christer, Blennow, Kaj, van Swieten, John C., Janelidze, Shorena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6529985/ https://www.ncbi.nlm.nih.gov/pubmed/31139684 http://dx.doi.org/10.1002/acn3.763

Ejemplares similares

Age-Related Incidence and Family History in Frontotemporal Dementia: Data from the Swedish Dementia Registry
por: Nilsson, Christer, et al.
Publicado: (2014)

Cerebrospinal fluid neurogranin and YKL‐40 as biomarkers of Alzheimer's disease
por: Janelidze, Shorena, et al.
Publicado: (2015)

Plasma neurofilament light protein correlates with diffusion tensor imaging metrics in frontotemporal dementia
por: Spotorno, Nicola, et al.
Publicado: (2020)

Cerebrospinal fluid neurofilament light chain protein levels in subtypes of frontotemporal dementia
por: Landqvist Waldö, Maria, et al.
Publicado: (2013)

Increased blood-brain barrier permeability is associated with dementia and diabetes but not amyloid pathology or APOE genotype
por: Janelidze, Shorena, et al.
Publicado: (2017)

(18)F-Flortaucipir in TDP-43 associated frontotemporal dementia
por: Smith, R., et al.
Publicado: (2019)

Diffusion Tensor Tractography versus Volumetric Imaging in the Diagnosis of Behavioral Variant Frontotemporal Dementia
por: Santillo, Alexander Frizell, et al.
Publicado: (2013)

CSF biomarkers of neuroinflammation and cerebrovascular dysfunction in early Alzheimer disease
por: Janelidze, Shorena, et al.
Publicado: (2018)

Prenatal gyrification pattern affects age at onset in frontotemporal dementia
por: Harper, Luke, et al.
Publicado: (2022)

Structural and microstructural thalamocortical network disruption in sporadic behavioural variant frontotemporal dementia
por: Jakabek, David, et al.
Publicado: (2023)

[(18)F]RO948 tau positron emission tomography in genetic and sporadic frontotemporal dementia syndromes
por: Santillo, Alexander F., et al.
Publicado: (2022)

Novel CSF biomarkers in genetic frontotemporal dementia identified by proteomics
por: van der Ende, Emma L., et al.
Publicado: (2019)

Plasma glial fibrillary acidic protein detects Alzheimer pathology and predicts future conversion to Alzheimer dementia in patients with mild cognitive impairment
por: Cicognola, Claudia, et al.
Publicado: (2021)

Psychotic symptoms in frontotemporal dementia: a diagnostic dilemma?
por: Landqvist Waldö, Maria, et al.
Publicado: (2015)

Towards a unified protocol for handling of CSF before β-amyloid measurements
por: Janelidze, Shorena, et al.
Publicado: (2019)

Association of Neuropathologically Confirmed Frontotemporal Dementia and Alzheimer Disease With Criminal and Socially Inappropriate Behavior in a Swedish Cohort
por: Liljegren, Madeleine, et al.
Publicado: (2019)

Blood and cerebrospinal fluid neurofilament light differentially detect neurodegeneration in early Alzheimer’s disease
por: Andersson, Emelie, et al.
Publicado: (2020)

von Economo neurones are selectively targeted in frontotemporal dementia
por: Santillo, A F, et al.
Publicado: (2013)

Slowly progressive dementia caused by MAPT R406W mutations: longitudinal report on a new kindred and systematic review
por: Ygland, Emil, et al.
Publicado: (2018)

Associations of CSF PDGFRβ With Aging, Blood-Brain Barrier Damage, Neuroinflammation, and Alzheimer Disease Pathologic Changes
por: Cicognola, Claudia, et al.
Publicado: (2023)

Associations Between CSF Markers of Inflammation, White Matter Lesions, and Cognitive Decline in Individuals Without Dementia
por: Gertje, Eske Christiane, et al.
Publicado: (2023)

CSF Aβ42/Aβ40 and Aβ42/Aβ38 ratios: better diagnostic markers of Alzheimer disease
por: Janelidze, Shorena, et al.
Publicado: (2016)

Increased CSF biomarkers of angiogenesis in Parkinson disease
por: Janelidze, Shorena, et al.
Publicado: (2015)

Grey and White Matter Clinico-Anatomical Correlates of Disinhibition in Neurodegenerative Disease
por: Santillo, Alexander Frizell, et al.
Publicado: (2016)

Association of CSF Aβ(38) Levels With Risk of Alzheimer Disease–Related Decline
por: Cullen, Nicholas, et al.
Publicado: (2022)

β-Amyloid–Dependent and –Independent Genetic Pathways Regulating CSF Tau Biomarkers in Alzheimer Disease
por: Kumar, Atul, et al.
Publicado: (2022)

Combining plasma phospho-tau and accessible measures to evaluate progression to Alzheimer’s dementia in mild cognitive impairment patients
por: Pichet Binette, Alexa, et al.
Publicado: (2022)

CSF synaptic protein concentrations are raised in those with atypical Alzheimer’s disease but not frontotemporal dementia
por: Clarke, Mica T. M., et al.
Publicado: (2019)

Tau PET correlates with different Alzheimer’s disease‐related features compared to CSF and plasma p‐tau biomarkers
por: Ossenkoppele, Rik, et al.
Publicado: (2021)

Neuronal pentraxin 2: a synapse-derived CSF biomarker in genetic frontotemporal dementia
por: van der Ende, Emma L, et al.
Publicado: (2020)

Contribution of CSF biomarkers to early‐onset Alzheimer's disease and frontotemporal dementia neuroimaging signatures
por: Falgàs, Neus, et al.
Publicado: (2020)

Elevated CSF and plasma complement proteins in genetic frontotemporal dementia: results from the GENFI study
por: van der Ende, Emma L., et al.
Publicado: (2022)

Clinical value of neurofilament and phospho-tau/tau ratio in the frontotemporal dementia spectrum
por: Meeter, Lieke H.H., et al.
Publicado: (2018)

Longitudinal multimodal MRI as prognostic and diagnostic biomarker in presymptomatic familial frontotemporal dementia
por: Jiskoot, Lize C, et al.
Publicado: (2019)

Longitudinal cognitive biomarkers predicting symptom onset in presymptomatic frontotemporal dementia
por: Jiskoot, Lize C., et al.
Publicado: (2018)

Anterior cingulate sulcation is associated with onset and survival in frontotemporal dementia
por: Harper, Luke, et al.
Publicado: (2023)

Endo‐lysosomal protein concentrations in CSF from patients with frontotemporal dementia caused by CHMP2B mutation
por: Toft, Anders, et al.
Publicado: (2023)

Striatal Atrophy in the Behavioural Variant of Frontotemporal Dementia: Correlation with Diagnosis, Negative Symptoms and Disease Severity
por: Macfarlane, Matthew D., et al.
Publicado: (2015)

Validation of a prefractionation method followed by two-dimensional electrophoresis – Applied to cerebrospinal fluid proteins from frontotemporal dementia patients
por: Hansson, Sara Folkesson, et al.
Publicado: (2004)

Clinical Value of Longitudinal Serum Neurofilament Light Chain in Prodromal Genetic Frontotemporal Dementia
por: Giannini, Lucia A.A., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_l5tb3tj32kg0j6v1353sjf0rnu